Connect your AI

Cohen & Steers CNS Derivative Instruments in Hedges, Liabilities, at Fair Value

Other financials

Income statement

Revenue$145.6M+8.3%

Operating income$50.1M+10.9%

Net income$42.4M+6.5%

EPS (diluted)$0.82+6.5%

Balance sheet

Cash & equivalents$56.3M-14.9%

Total debt$136.3M-2.7%

Total equity$563.4M+11.0%

Total assets$854.7M+2.4%

Cash flow

Operating cash flow-$51.4M+52.9%

CapEx$282.0K-83.2%

Free cash flow-$69.8M-357%

Valuation

Market cap$3.85B-21.4%

Enterprise value$3.93B-20.9%

P/E24.7×-6.5×

P/S6.8×-2.5×

Profitability

Operating margin32.2%-1.4pp

Net margin27.5%-2.2pp

FCF margin-22.5%-48.0pp

Returns & leverage

Return on equity29.1%-6.3pp

Debt / equity0.2×0.0×

Where this comes from

Reported directly by Cohen & Steers in its filing.

Tagged under the XBRL concept us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue.

The official record: Cohen & Steers’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cohen & Steers's derivative instruments in hedges, liabilities, at fair value.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Cohen & Steers's derivative instruments in hedges, liabilities, at fair value?: Cohen & Steers (CNS) reported derivative instruments in hedges, liabilities, at fair value of $2.87M in Q1 2026.